Clinical trial
A Phase I Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer
NCT01304602 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- October 31, 2015
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer